Skip to main content
SpringerLink
Log in

Dementia Due to Neurodegenerative Disease: Molecular Imaging Findings

  • Chapter
  • First Online:
PET and SPECT in Neurology

Abstract

This chapter focuses on molecular imaging in dementia using PET and SPECT. The performance of FDG-PET, PIB-PET, and DAT SPECT in the differential and early diagnosis of dementia will be evaluated. Finally, more experimental PET tracers will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agdeppa E, Kepe V, Liu J, Flores-Torres S et al (2001) Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer’s disease. J Neurosci 15:RC189

    Google Scholar 

  • Aisen PS, Schmeidler J, Pasinetti GM (2002) Randomized pilot study of nimesulide treatment in Alzheimer’s disease. Neurology 58:1050–1054

    CAS  PubMed  Google Scholar 

  • Aisen PS, Schafer KA, Grundman M, Pfeiffer E et al (2003) Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289: 2819–2826

    CAS  PubMed  Google Scholar 

  • Albert MS, DeKosky ST, Dickson D, Dubois B et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279

    PubMed Central  PubMed  Google Scholar 

  • Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM (2002) Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer’s disease treatment studies. Am J Psychiatry 159:738–745

    PubMed  Google Scholar 

  • Attwell D, Laughlin SB (2001) An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab 21:1133–1145

    CAS  PubMed  Google Scholar 

  • Auning E, Rongve A, Fladby T, Booij J et al (2011) Early and presenting symptoms of dementia with Lewy bodies. Dement Geriatr Cogn Disord 32:202–208

    PubMed  Google Scholar 

  • Barthel H, Gertz HJ, Dresel S, Peters O et al (2011) Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer’s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol 10:424–435

    CAS  PubMed  Google Scholar 

  • Becker JA, Hedden T, Carmasin J, Maye J et al (2011) Amyloid-β associated cortical thinning in clinically normal elderly. Ann Neurol 69:1032–1042

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bergfield KL, Hanson KD, Chen K, Teipel SJ et al (2010) Age-related networks of regional covariance in MRI gray matter: reproducible multivariate patterns in healthy aging. Neuroimage 49:1750–1759

    PubMed Central  PubMed  Google Scholar 

  • Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer’s disease. Lancet Neurol 2:605–613

    CAS  PubMed  Google Scholar 

  • Bohnen N, Kaufer D, Hendrickson R, Ivanco L et al (2005) Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 76:315–319

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bohnen NI, Djang DS, Herholz K, Anzai Y, Minoshima S (2012) Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med 53:59–71

    CAS  PubMed  Google Scholar 

  • Booij J, Teune LK, Verberne HJ (2012) The role of molecular imaging in the differential diagnosis of parkinsonism. Q J Nucl Med Mol Imaging 56:17–26

    CAS  PubMed  Google Scholar 

  • Boutin H, Chauveau F, Thominiaux C, Kuhnast B et al (2007) In vivo imaging of brain lesions with [(11)C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors. Glia 55:1459–1468

    PubMed  Google Scholar 

  • Briard E, Zoghbi SS, Imaizumi M, Gourley JP et al (2008) Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo. J Med Chem 51:17–30

    CAS  PubMed  Google Scholar 

  • Brix G, Zaers J, Adam LE, Bellemann ME et al (1997) Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 38:1614–1623

    CAS  PubMed  Google Scholar 

  • Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K et al (1992) Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 49:935–942

    CAS  PubMed  Google Scholar 

  • Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L et al (2010) In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology 74:77–84

    CAS  PubMed Central  PubMed  Google Scholar 

  • Burke JF, Albin RL, Koeppe RA, Giordani B et al (2011) Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain 134:1647–1657

    PubMed Central  PubMed  Google Scholar 

  • Cabeza R, Anderson ND, Locantore JK, McIntosh AR (2002) Aging gracefully: compensatory brain activity in high-performing older adults. Neuroimage 17:1394–1402

    PubMed  Google Scholar 

  • Cagnin A, Brooks DJ, Kennedy AM, Gunn RN et al (2001) In-vivo measurement of activated microglia in dementia. Lancet 358:461–467

    CAS  PubMed  Google Scholar 

  • Camacho V, Marquié M, Lleó A, Alvés L et al (2011) Cardiac sympathetic impairment parallels nigrostriatal degeneration in probable Dementia with Lewy bodies. Q J Nucl Med Mol Imaging 55:476–483

    CAS  PubMed  Google Scholar 

  • Carter S, Schöll M, Almkvist O, Wall A et al (2012) Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med 53:37–46

    CAS  PubMed  Google Scholar 

  • Caso F, Gesierich B, Henry M, Sidhu M et al (2012) Nonfluent/agrammatic PPA with in-vivo cortical amyloidosis and Pick’s disease pathology. Behav Neurol 26(1–2):95–106

    Google Scholar 

  • Chen MK, Guilarte TR (2006) Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. Toxicol Sci 91:532–539

    CAS  PubMed  Google Scholar 

  • Chen WP, Samuraki M, Yanase D, Shima K et al (2008) Effect of sample size for normal database on diagnostic performance of brain FDG PET for the detection of Alzheimer’s disease using automated image analysis. Nucl Med Commun 29:270–276

    PubMed  Google Scholar 

  • Chételat G, Desgranges B, de la Sayette V, Viader F et al (2003) Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease? Neurology 60:1374–1377

    PubMed  Google Scholar 

  • Chételat G, Villemagne VL, Bourgeat P, Pike KE et al (2010) Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol 67:317–324

    PubMed  Google Scholar 

  • Clark CM, Schneider JA, Bedell BJ, Beach TG et al (2011) Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 305:275–283

    CAS  PubMed  Google Scholar 

  • Cohen AD, Price JC, Weissfeld LA, James J et al (2009) Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci 29:14770–14778

    CAS  PubMed Central  PubMed  Google Scholar 

  • DeCarli C (2003) Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol 2:15–21

    PubMed  Google Scholar 

  • Dickerson BC, Bakkour A, Salat DH, Feczko E et al (2009) The cortical signature of Alzheimer’s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 19:497–510

    PubMed Central  PubMed  Google Scholar 

  • Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S et al (2007) Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging 28:42–50

    CAS  PubMed  Google Scholar 

  • DiPatre PL, Gelman BB (1997) Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. J Neuropathol Exp Neurol 56:143–149

    CAS  PubMed  Google Scholar 

  • Donnemiller E, Heilmann J, Wenning GK, Berger W et al (1997) Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med 24:320–325

    CAS  PubMed  Google Scholar 

  • Doorduin J, Klein HC, Dierckx RA, James M et al (2009) [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis. Mol Imaging Biol 11:386–398

    PubMed Central  PubMed  Google Scholar 

  • Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M et al (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer’s disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30:1104–1113

    PubMed  Google Scholar 

  • Dubois B, Feldman HH, Jacova C, Dekosky ST et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746

    PubMed  Google Scholar 

  • Engler H, Santillo AF, Wang SX, Lindau M et al (2008) In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging 35:100–106

    PubMed  Google Scholar 

  • Fagan AM, Mintun MA, Mach RH, Lee SY et al (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59:512–519

    CAS  PubMed  Google Scholar 

  • Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C (2009) Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol 66:1151–1157

    PubMed Central  PubMed  Google Scholar 

  • Fleisher AS, Chen K, Liu X, Ayutyanont N et al (2012) Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging 34(1):1–12

    PubMed  Google Scholar 

  • Foster NL, Chase TN, Mansi L, Brooks R et al (1984) Cortical abnormalities in Alzheimer’s disease. Ann Neurol 16:649–654

    CAS  PubMed  Google Scholar 

  • Foster NL, Heidebrink JL, Clark CM, Jagust WJ et al (2007) FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease. Brain 130:2616–2635

    PubMed  Google Scholar 

  • Fowler J, MacGregor R, Wolf A, Arnett C et al (1987) Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET. Science 23:481–485

    Google Scholar 

  • Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atypical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123:484–498

    PubMed  Google Scholar 

  • Gavish M, Bachman I, Shoukrun R, Katz Y et al (1999) Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev 51:629–650

    CAS  PubMed  Google Scholar 

  • Gilman S, Koeppe RA, Little R, An H et al (2004) Striatal monoamine terminals in Lewy body dementia and Alzheimer’s disease. Ann Neurol 55:774–780

    PubMed  Google Scholar 

  • Giulian D, Haverkamp LJ, Yu JH, Karshin W et al (1996) Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci 16:6021–6037

    CAS  PubMed  Google Scholar 

  • Goldstein DS, Holmes C, Cannon RO, Eisenhofer G, Kopin IJ (1997) Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 336:696–702

    CAS  PubMed  Google Scholar 

  • Gomperts SN, Rentz DM, Moran E, Becker JA et al (2008) Imaging amyloid deposition in Lewy body diseases. Neurology 71:903–910

    CAS  PubMed Central  PubMed  Google Scholar 

  • Harding AJ, Halliday GM (2001) Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol 102:355–363

    CAS  PubMed  Google Scholar 

  • Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185

    CAS  PubMed  Google Scholar 

  • Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356

    CAS  PubMed  Google Scholar 

  • Herholz K, Bauer B, Wienhard K, Kracht L et al (2000) In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism. J Neural Transm 107:1457–1468

    CAS  PubMed  Google Scholar 

  • Herholz K, Salmon E, Perani D, Baron JC et al (2002) Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17:302–316

    CAS  PubMed  Google Scholar 

  • Herholz K, Carter S, Jones M (2007) Positron emission tomography imaging in dementia. Br J Radiol 80:2S160–2S167

    Google Scholar 

  • Holthoff VA, Beuthien-Baumann B, Zündorf G, Triemer A et al (2004) Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand 110:184–194

    CAS  PubMed  Google Scholar 

  • Hosaka K, Ishii K, Sakamoto S, Mori T et al (2002) Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. J Neurol Sci 199:67–71

    CAS  PubMed  Google Scholar 

  • Hu XS, Okamura N, Arai H, Higuchi M et al (2000) 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology 55:1575–1577

    CAS  PubMed  Google Scholar 

  • Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA et al (2008) Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain 131:1630–1645

    PubMed Central  PubMed  Google Scholar 

  • Ikonomovic MD, Abrahamson EE, Price JC, Hamilton RL et al (2012) Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study. Acta Neuropathol 123:433–447

    CAS  PubMed Central  PubMed  Google Scholar 

  • Iranzo A, Lomeña F, Stockner H, Valldeoriola F et al (2010) Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 9:1070–1077

    CAS  PubMed  Google Scholar 

  • Ishii K, Imamura T, Sasaki M, Yamaji S et al (1998a) Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer’s disease. Neurology 51:125–130

    CAS  PubMed  Google Scholar 

  • Ishii K, Sakamoto S, Sasaki M, Kitagaki H et al (1998b) Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 39:1875–1878

    CAS  PubMed  Google Scholar 

  • Ishii K, Soma T, Kono AK, Sofue K et al (2007) Comparison of regional brain volume and glucose metabolism between patients with mild dementia with Lewy bodies and those with mild Alzheimer’s disease. J Nucl Med 48:704–711

    PubMed  Google Scholar 

  • Iyo M, Namba H, Fukushi K, Shinotoh H et al (1997) Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer’s disease. Lancet 21:1805–1809

    Google Scholar 

  • Jagust W, Reed B, Mungas D, Ellis W, Decarli C (2007) What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology 69:871–877

    CAS  PubMed  Google Scholar 

  • Jagust WJ, Landau SM, Shaw LM, Trojanowski JQ et al (2009) Relationships between biomarkers in aging and dementia. Neurology 73:1193–1199

    CAS  PubMed Central  PubMed  Google Scholar 

  • Johnson KA, Gregas M, Becker JA, Kinnecom C et al (2007) Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 62:229–234

    PubMed  Google Scholar 

  • Juh R, Pae CU, Kim TS, Lee CU et al (2005) Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci Lett 383:22–27

    CAS  PubMed  Google Scholar 

  • Kaasinen V, Någren K, Järvenpää T, Roivainen A et al (2002) Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer’s disease. J Clin Psychopharmacol 22:615–620

    CAS  PubMed  Google Scholar 

  • Kadir A, Darreh-Shori T, Almkvist O, Wall A et al (2008) PET imaging of the in vivo brain acetylcholinesterase activity and nicotine binding in galantamine-treated patients with AD. Neurobiol Aging 29:1204–1217

    CAS  PubMed  Google Scholar 

  • Kasanuki K, Iseki E, Fujishiro H, Yamamoto R et al (2012) Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies. J Neurol Sci 314:111–119

    CAS  PubMed  Google Scholar 

  • Kashihara K, Ohno M, Kawada S, Okumura Y (2006) Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson’s disease and dementia with Lewy bodies. J Nucl Med 47:1099–1101

    CAS  PubMed  Google Scholar 

  • King AE, Mintz J, Royall DR (2011) Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders. Mov Disord 26:1218–1224

    PubMed  Google Scholar 

  • Klunk WE (2011) Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia. Neurobiol Aging 32(Suppl 1):S20–S36

    CAS  PubMed Central  PubMed  Google Scholar 

  • Klunk WE, Wang Y, Huang GF, Debnath ML et al (2003) The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci 23:2086–2092

    CAS  PubMed  Google Scholar 

  • Klunk WE, Engler H, Nordberg A, Wang Y et al (2004) Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 55:306–319

    CAS  PubMed  Google Scholar 

  • Knopman DS, DeKosky ST, Cummings JL, Chui H et al (2001) Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:1143–1153

    CAS  PubMed  Google Scholar 

  • Koeppe RA, Gilman S, Junck L, Wernette K, Frey KA (2008) Differentiating Alzheimer’s disease from dementia with Lewy bodies and Parkinson’s disease with (+)-[11C]dihydrotetrabenazine positron emission tomography. Alzheimers Dement 4:S67–S76

    PubMed  Google Scholar 

  • Koivunen J, Pirttilä T, Kemppainen N, Aalto S et al (2008) PET amyloid ligand [11C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment. Dement Geriatr Cogn Disord 26:378–383

    CAS  PubMed  Google Scholar 

  • Koivunen J, Scheinin N, Virta JR, Aalto S et al (2011) Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study. Neurology 22:1085–1090

    Google Scholar 

  • Kreisl WC, Fujita M, Fujimura Y, Kimura N et al (2010) Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker. Neuroimage 49:2924–2932

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312–318

    CAS  PubMed  Google Scholar 

  • Kuhl D, Koeppe R, Minoshima S, Snyder S et al (1999) In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease. Neurology 10:691–699

    Google Scholar 

  • Landau SM, Harvey D, Madison CM, Reiman EM et al (2010) Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 75:230–238

    CAS  PubMed Central  PubMed  Google Scholar 

  • Landau SM, Harvey D, Madison CM, Koeppe RA et al (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32:1207–1218

    PubMed Central  PubMed  Google Scholar 

  • Lee JH, Kim SH, Kim GH, Seo SW et al (2011) Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology 77:18–25

    CAS  PubMed  Google Scholar 

  • Leinonen V, Alafuzoff I, Aalto S, Suotunen T et al (2008) Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh compound B. Arch Neurol 65:1304–1309

    PubMed  Google Scholar 

  • Lim SM, Katsifis A, Villemagne VL, Best R et al (2009) The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med 50:1638–1645

    CAS  PubMed  Google Scholar 

  • Maeda J, Suhara T, Zhang MR, Okauchi T et al (2004) Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: an imaging tool for glial cells in the brain. Synapse 52:283–291

    CAS  PubMed  Google Scholar 

  • McGeer PL, Itagaki S, McGeer EG (1988) Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol 76:550–557

    CAS  PubMed  Google Scholar 

  • McKeith IG, Galasko D, Kosaka K, Perry EK et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124

    CAS  PubMed  Google Scholar 

  • McKeith IG, Dickson DW, Lowe J, Emre M et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863–1872

    CAS  PubMed  Google Scholar 

  • McKeith I, O’Brien J, Walker Z, Tatsch K et al (2007) Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6:305–313

    PubMed  Google Scholar 

  • McKhann G, Drachman D, Folstein M, Katzman R et al (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–944

    CAS  PubMed  Google Scholar 

  • McKhann GM, Knopman DS, Chertkow H, Hyman BT et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269

    PubMed Central  PubMed  Google Scholar 

  • McMurtray AM, Licht E, Yeo T, Krisztal E et al (2008) Positron emission tomography facilitates diagnosis of early-onset alzheimer’s disease. Eur Neurol 59:31–37

    PubMed  Google Scholar 

  • Minoshima S, Foster NL, Kuhl DE (1994) Posterior cingulate cortex in Alzheimer’s disease. Lancet 24:895

    Google Scholar 

  • Minoshima S, Foster NL, Sima AA, Frey KA et al (2001) Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 50:358–365

    CAS  PubMed  Google Scholar 

  • Mizukami K, Homma T, Aonuma K, Kinoshita T et al (2009) Decreased ventilatory response to hypercapnia in dementia with Lewy bodies. Ann Neurol 65:614–617

    PubMed  Google Scholar 

  • Moeller JR, Ishikawa T, Dhawan V, Spetsieris P et al (1996) The metabolic topography of normal aging. J Cereb Blood Flow Metab 16:385–398

    CAS  PubMed  Google Scholar 

  • Moreno-López L, Stamatakis EA, Fernández-Serrano MJ, Gómez-Río M et al (2012) Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study. PLoS One 7:e39830

    PubMed Central  PubMed  Google Scholar 

  • Morgan S, Kemp P, Booij J, Costa DC et al (2012) Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT. J Neurol Neurosurg Psychiatry 83:1063–1070

    PubMed  Google Scholar 

  • Mormino EC, Kluth JT, Madison CM, Rabinovici GD et al (2009) Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 132:1310–1323

    CAS  PubMed Central  PubMed  Google Scholar 

  • Mormino EC, Brandel MG, Madison CM, Marks S et al (2012) Aβ deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb Cortex 22:1813–1823

    PubMed Central  PubMed  Google Scholar 

  • Morris JC, Roe CM, Grant EA, Head D et al (2009) Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch Neurol 66:1469–1475

    PubMed Central  PubMed  Google Scholar 

  • Mosconi L, Tsui WH, Pupi A, De Santi S et al (2007) (18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer’s disease. J Nucl Med 48:1129–1134

    PubMed  Google Scholar 

  • Mosconi L, Tsui WH, Herholz K, Pupi A et al (2008) Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. J Nucl Med 49:390–398

    PubMed Central  PubMed  Google Scholar 

  • Mourik JE, Lubberink M, van Velden FH, Kloet RW et al (2010) In vivo validation of reconstruction-based resolution recovery for human brain studies. J Cereb Blood Flow Metab 30:381–389

    PubMed Central  PubMed  Google Scholar 

  • Neary D, Snowden JS, Gustafson L, Passant U et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554

    CAS  PubMed  Google Scholar 

  • Ng S, Villemagne VL, Berlangieri S, Lee ST et al (2007) Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer’s disease. J Nucl Med 48:547–552

    CAS  PubMed  Google Scholar 

  • O’Brien JT, Colloby S, Fenwick J, Williams ED et al (2004) Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 61:919–925

    PubMed  Google Scholar 

  • O’Brien JT, McKeith IG, Walker Z, Tatsch K et al (2009) Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 194:34–39

    PubMed  Google Scholar 

  • Oh H, Mormino EC, Madison C, Hayenga A et al (2011) β-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage 54:1887–1895

    CAS  PubMed Central  PubMed  Google Scholar 

  • Okello A, Edison P, Archer HA, Turkheimer FE et al (2009) Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 72:56–62

    CAS  PubMed Central  PubMed  Google Scholar 

  • Orimo S, Uchihara T, Nakamura A, Mori F et al (2008) Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson’s disease. Brain 131:642–650

    PubMed  Google Scholar 

  • Ossenkoppele R, van Berckel BN, Prins ND (2011) Amyloid imaging in prodromal Alzheimer’s disease. Alzheimers Res Ther 3:26–28

    CAS  PubMed Central  PubMed  Google Scholar 

  • Ossenkoppele R, Prins ND, Pijnenburg YA, Lemstra AW et al (2012a) Impact of molecular imaging on the diagnostic process in a memory clinic. Alzheimers Dement 9(4):414–421

    PubMed  Google Scholar 

  • Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF et al (2012b) Longitudinal imaging of Alzheimer pathology using [(11)C]PIB, [(18)F]FDDNP and [(18)F]FDG PET. Eur J Nucl Med Mol Imaging 39(6):990–1000

    CAS  PubMed  Google Scholar 

  • Owen DR, Howell OW, Tang SP, Wells LA et al (2010) Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation. J Cereb Blood Flow Metab 30:1608–1618

    PubMed Central  PubMed  Google Scholar 

  • Owen DR, Gunn RN, Rabiner EA, Bennacef I et al (2011) Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med 52:24–32

    CAS  PubMed Central  PubMed  Google Scholar 

  • Panegyres PK, Rogers JM, McCarthy M, Campbell A, Wu JS (2009) Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study. BMC Neurol 9:41

    PubMed Central  PubMed  Google Scholar 

  • Papathanasiou ND, Boutsiadis A, Dickson J, Bomanji JB (2012) Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies. Parkinsonism Relat Disord 18:225–229

    PubMed  Google Scholar 

  • Park DC, Reuter-Lorenz P (2009) The adaptive brain: aging and neurocognitive scaffolding. Annu Rev Psychol 60:173–196

    PubMed Central  PubMed  Google Scholar 

  • Perry E, Court J, Goodchild R, Griffiths M et al (1998) Clinical neurochemistry: developments in dementia research based on brain bank material. J Neural Transm 105:915–933

    CAS  PubMed  Google Scholar 

  • Petersen RC, Smith GE, Waring SC, Ivnik RJ et al (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308

    CAS  PubMed  Google Scholar 

  • Piggott MA, Marshall EF, Thomas N, Lloyd S et al (1999) Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer’s and Parkinson’s diseases: rostrocaudal distribution. Brain 122(Pt 8):1449–1468

    PubMed  Google Scholar 

  • Rabinovici GD, Rosen HJ, Alkalay A, Kornak J et al (2011) Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology 77:2034–2042

    CAS  PubMed Central  PubMed  Google Scholar 

  • Rascovsky K, Hodges JR, Knopman D, Mendez MF et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456–2477

    PubMed Central  PubMed  Google Scholar 

  • Reischle E, Sturm K, Schuierer G, Ibach B (2003) A case of schizophreniform disorder in frontotemporal dementia (FTD). Psychiatr Prax 30(Suppl 2):S78–S82

    PubMed  Google Scholar 

  • Resnick SM, Sojkova J, Zhou Y, An Y et al (2010) Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology 74:807–815

    CAS  PubMed Central  PubMed  Google Scholar 

  • Rinne J, Kaasinen V, Järvenpää T, Någren K et al (2003) Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer’s disease. J Neurol Neurosurg Psychiatry 74:113–115

    CAS  PubMed Central  PubMed  Google Scholar 

  • Rocher AB, Chapon F, Blaizot X, Baron JC, Chavoix C (2003) Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage 20:1894–1898

    PubMed  Google Scholar 

  • Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43:250–260

    PubMed  Google Scholar 

  • Roselli F, Pisciotta NM, Perneczky R, Pennelli M et al (2009) Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. Mov Disord 24:2097–2103

    PubMed  Google Scholar 

  • Rosen AC, Prull MW, O’Hara R, Race EA et al (2002) Variable effects of aging on frontal lobe contributions to memory. Neuroreport 13:2425–2428

    PubMed  Google Scholar 

  • Rowe CC, Ellis KA, Rimajova M, Bourgeat P et al (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31:1275–1283

    PubMed  Google Scholar 

  • Rozemuller JM, Eikelenboom P, Pals ST, Stam FC (1989) Microglial cells around amyloid plaques in Alzheimer’s disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci Lett 101:288–292

    CAS  PubMed  Google Scholar 

  • Salmon E, Garraux G, Delbeuck X, Collette F et al (2003) Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia. Neuroimage 20:435–440

    PubMed  Google Scholar 

  • Salmon E, Kerrouche N, Herholz K, Perani D et al (2006) Decomposition of metabolic brain clusters in the frontal variant of frontotemporal dementia. Neuroimage 30:871–878

    PubMed  Google Scholar 

  • Sánchez-Pernaute R, Ferree A, Cooper O, Yu M et al (2004) Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson’s disease. J Neuroinflammation 1:6

    PubMed Central  PubMed  Google Scholar 

  • Scheltens P, Leys D, Barkhof F, Huglo D et al (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967–972

    CAS  PubMed Central  PubMed  Google Scholar 

  • Schöll M, Wall A, Thordardottir S, Ferreira D et al (2012) Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers. Neurology 79:229–236

    PubMed  Google Scholar 

  • Schuitemaker A, Kropholler MA, Boellaard R, van der Flier WM et al (2012) Microglial activation in Alzheimer’s disease: an (R)-[(11)C]PK11195 positron emission tomography study. Neurobiol Aging 34:128–136

    PubMed  Google Scholar 

  • Silverman DH, Small GW, Chang CY, Lu CS et al (2001) Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 286:2120–2127

    CAS  PubMed  Google Scholar 

  • Small G, Kepe V, Ercoli L, Siddarth P et al (2006) PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med 21:2652–2663

    Google Scholar 

  • Sperling RA, Aisen PS, Beckett LA, Bennett DA et al (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292

    PubMed Central  PubMed  Google Scholar 

  • Storandt M, Mintun MA, Head D, Morris JC (2009) Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Arch Neurol 66:1476–1481

    PubMed Central  PubMed  Google Scholar 

  • Streit WJ, Graeber MB, Kreutzberg GW (1988) Functional plasticity of microglia: a review. Glia 1:301–307

    CAS  PubMed  Google Scholar 

  • Streit WJ, Braak H, Xue QS, Bechmann I (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol 118:475–485

    PubMed Central  PubMed  Google Scholar 

  • Stubendorff K, Aarsland D, Minthon L, Londos E (2012) The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson’s disease with dementia. PLoS One 7:e45451

    CAS  PubMed Central  PubMed  Google Scholar 

  • Suzuki M, Kurita A, Hashimoto M, Fukumitsu N et al (2006) Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson’s disease. J Neurol Sci 240:15–19

    CAS  PubMed  Google Scholar 

  • Taki J, Yoshita M, Yamada M, Tonami N (2004) Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson’s disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 18:453–461

    PubMed  Google Scholar 

  • Teune LK, Bartels AL, de Jong BM, Willemsen AT et al (2010) Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 25:2395–2404

    PubMed  Google Scholar 

  • Thaisetthawatkul P, Boeve BF, Benarroch EE, Sandroni P et al (2004) Autonomic dysfunction in dementia with Lewy bodies. Neurology 62:1804–1809

    CAS  PubMed  Google Scholar 

  • Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800

    PubMed  Google Scholar 

  • Tolboom N, van der Flier WM, Yaqub M, Boellaard R et al (2009a) Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding. J Nucl Med 50:1464–1470

    CAS  PubMed  Google Scholar 

  • Tolboom N, Yaqub M, van der Flier W, Boellaard R et al (2009b) Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET. J Nucl Med 50:191–197

    PubMed  Google Scholar 

  • Tolboom N, van der Flier WM, Boverhoff J, Yaqub M et al (2010) Molecular imaging in the diagnosis of Alzheimer’s disease: visual assessment of [11C]PIB and [18F]FDDNP PET images. J Neurol Neurosurg Psychiatry 81:882–884

    PubMed  Google Scholar 

  • Toru S, Uchihara T, Takahashi M, Ichihara K et al (2010) Depletion or preservation of cardiac sympathetic nerve – an autopsy-verified contrast in two cases of Alzheimer’s disease with or without Lewy bodies. Eur Neurol 64:129–133

    PubMed  Google Scholar 

  • Van Gool WA, Weinstein HC, Scheltens P, Walstra GJ, Scheltens PK (2001) Effect of hydroxychloroquine on progression of dementia in early Alzheimer’s disease: an 18-month randomised, double-blind, placebo-controlled study. Lancet 358:455–460

    PubMed  Google Scholar 

  • Van Laere K, Casteels C, De Ceuninck L, Vanbilloen B et al (2006) Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis. J Nucl Med 47:384–392

    PubMed  Google Scholar 

  • Vandenberghe R, Van Laere K, Ivanoiu A, Salmon E et al (2010) 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol 68:319–329

    PubMed  Google Scholar 

  • Veerhuis R, Van Breemen MJ, Hoozemans JM, Morbin M et al (2003) Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Acta Neuropathol 105:135–144

    CAS  PubMed  Google Scholar 

  • Verwey NA, van der Flier WM, Blennow K, Clark C et al (2009) A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer’s disease. Ann Clin Biochem 46:235–240

    CAS  PubMed  Google Scholar 

  • Villemagne VL, McLean CA, Reardon K, Boyd A et al (2009) 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 80:998–1001

    CAS  PubMed  Google Scholar 

  • Villemagne VL, Okamura N, Pejoska S, Drago J et al (2011a) In vivo assessment of vesicular monoamine transporter type 2 in dementia with Lewy bodies and Alzheimer disease. Arch Neurol 68:905–912

    PubMed  Google Scholar 

  • Villemagne VL, Pike KE, Chételat G, Ellis KA et al (2011b) Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol 69:181–192

    CAS  PubMed Central  PubMed  Google Scholar 

  • Villemagne VL, Okamura N, Pejoska S, Drago J et al (2012) Differential diagnosis in Alzheimer’s disease and dementia with Lewy bodies via VMAT2 and amyloid imaging. Neurodegener Dis 10:161–165

    CAS  PubMed  Google Scholar 

  • Vlassenko AG, Mintun MA, Xiong C, Sheline YI et al (2011) Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data. Ann Neurol 70:857–861

    CAS  PubMed Central  PubMed  Google Scholar 

  • Walker Z, Costa P, Ince I, McKeith C et al (1999) In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet 354:646–647

    CAS  PubMed  Google Scholar 

  • Walker Z, Costa DC, Walker RW, Shaw K et al (2002) Differentiation of dementia with Lewy bodies from Alzheimer’s disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 73:134–140

    CAS  PubMed Central  PubMed  Google Scholar 

  • Walker Z, Jaros E, Walker RW, Lee L et al (2007) Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 78:1176–1181

    PubMed Central  PubMed  Google Scholar 

  • Yaqub M, van Berckel BN, Schuitemaker A, Hinz R et al (2012) Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies. J Cereb Blood Flow Metab 32:1600–1608

    CAS  PubMed Central  PubMed  Google Scholar 

  • Yoshita M, Taki J, Yokoyama K, Noguchi-Shinohara M et al (2006) Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 66:1850–1854

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology and Nuclear Medicine & Alzheimer Center and Neurology, VU University Medical Center, 7057, Amsterdam, 1007MB, The Netherlands

    Rik Ossenkoppele & Bart N. M. van Berckel

  2. Department of Nuclear Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

    Jan Booij

  3. Alzheimer Center and Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, 7057, Amsterdam, 1007MB, The Netherlands

    Philip Scheltens

Authors
  1. Rik Ossenkoppele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan Booij
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philip Scheltens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bart N. M. van Berckel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rik Ossenkoppele .

Editor information

Editors and Affiliations

  1. Dept. of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

    Rudi A.J.O. Dierckx

  2. Faculty of Electrical Engineering and Information Technology, University of Applied Sciences Offenburg, Offenburg, Germany

    Andreas Otte

  3. Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands

    Erik F.J. de Vries

  4. Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, The Netherlands

    Aren van Waarde

  5. Neurology, University Medical Center Groningen, Groningen, The Netherlands

    Klaus L. Leenders

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ossenkoppele, R., Booij, J., Scheltens, P., van Berckel, B.N.M. (2014). Dementia Due to Neurodegenerative Disease: Molecular Imaging Findings. In: Dierckx, R., Otte, A., de Vries, E., van Waarde, A., Leenders, K. (eds) PET and SPECT in Neurology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54307-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54307-4_9

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54306-7

  • Online ISBN: 978-3-642-54307-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation